Advanced search

Currently, Camille Bonnel is Head-Research at Tritax Big Box REIT Plc. In the past Ms. Bonnel was Research Analyst at Merrill Lynch International and Analyst at RBC Europe Ltd. (Broker).

Dr. Camille L. Bedrosian, MD, is an Independent Director at Rhythm Pharmaceuticals, Inc., an Independent Director at Crinetics Pharmaceuticals, Inc., a Chief Medical Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc., a Member at American Society of Clinical Oncology, a Member at American Society of Hematology and a Member at American Society of Nephrology. She is on the Board of Directors at Rhythm Pharmaceuticals, Inc. and Crinetics Pharmaceuticals, Inc. Dr. Bedrosian was previously employed as a Chief Medical Officer & Senior Vice President by Alexion Pharmaceuticals, Inc., a Chief Medical Officer & Vice President by ARIAD Pharmaceuticals, Inc., a Senior Director-Oncology & Hematology by Genetics Institute, Inc., a Member by American Association for Cancer Research, a Member by American Association for the Advancement of Science, a Member by Duke Comprehensive Cancer Center, and an Assistant Professor by Duke University Medical Center. She received her undergraduate degree from Harvard University, a graduate degree from Massachusetts Institute of Technology and a doctorate degree from Harvard Medical School.

Camille Jojo is currently working as the Executive Director & Head-Legal & Compliance at Techtronic Industries Co., Ltd.
Prior to this, Mr. Jojo worked as a Member at the Chartered Institute of Arbitrators (East Asia Branch) and as a Partner at Norton Rose Fulbright (Services) Ltd.
Mr. Jojo graduated from the University of Cardiff in 1977.

Ms. Camille Burckhart is a Chief Information & Digital Officer, Executive VP at Popular, Inc. She is on the Board of Directors at Fundación Banco Popular, Inc. and Nuestra Escuela, Inc.

Boss of the holding company Carlo Tassara International, Romain Zaleski is the eighth richest man in France according to the professional magazine Challenges. Arcelor shareholders with 7.8%, he holds 13% of French metals group Eramet, 2% stake in the insurer Generali and 3% stake in Vinci alongside another Baron, Francois Pinault.

Son of an intellectual Polish and a mother doctor, Romain Zaleski grew up in a famous family of the Polish aristocracy. In 1943, his father, who had joined the resistance is arrested in France before being deported to Buschenwald. A year later, it was his mother who was deported to Ravensbruck.

In 1951, Romain Zaleski accessit gets a diploma in math and physics, which opened the doors of Polytechnic in 1953. In 1958, he graduated from the famous Ecole Nationale Supérieure des Mines de Paris before joining the civil service. He worked in various ministries including the Ministry of Industry before leaving in 1972 for Revillon, a financial company where he worked for seven years.

During his consulting projects he did for Camilog, he visits the factory of steel Carlo Tassara that has cash flow problems.
Convinced that intelligent management would avoid the bankruptcy, he took the helm and he avoids bankruptcy. This successful experience encouraged him to invest in multiple companies specializing in steel and energy. In recent years, he is considered as a specialist of business rescue in peril.

In Italy, he has invested in many banks. He is a notable, especially since the day where he allowed EDF to get Montedison.
In 2005, His rigor and discretion allow him to be an intermediate in the transaction that allows the merger of Arcelor and Mittal.

In 2009, Romain Zaleski has seen his fortune reduced by over 60% becoming the fourth richest man in France.

Currently, Gérard Rene Camille Deman occupies the position of Chairman & Chief Executive Officer for Drakkar Holdings SA and Chairman for Adisseo France SAS. He is also on the board of China National BlueStar (Group) Co., Ltd., Bluestar Adisseo Co. (former Chairman) and Bluestar Adisseo Nutrition Group Ltd. Mr. Deman previously occupied the position of Director-Manufacturing, Purchasing & Supply Chain at Aventis Animal Nutrition, Inc. and Vice President-Corporate Manufacturing at Solvay France SA.

Dr. Christophe Bonnel, MD, is a Director-Medical at Intrasense SA.

Antoine Bonnel had founded a company called Wabel SAS in 2012 and held the title of Managing Director.

Julien Bonnel is currently the Chief Executive Officer at Evariste SAS since 2020.
Prior to this, he worked as a Director at Rexel SA. He also served as the Sales Director & Chief Transformation Officer at Rexel Spain SL from 2018 to 2023.
Mr. Bonnel is a graduate of École Centrale Paris.

Nicolas Bonnel worked as a Director of Finance at Interbrew France SA.

Paul-César Bonnel has worked as a Director of Finance and Administration at Neurones SA since 2010.

Camille F.
Sarrouf is currently the Director at St. Jude Children's Research Hospital, Inc. He previously served as the Chairman at American Lebanese Syrian Associated Charities, Inc.

Camille I.
Farhat currently works at Safeguard Medical LLC, as Executive Chairman from 2022, Advanced Medical Technology Association, as Director, Northwestern Memorial Hospital, as Advisory Council Member, and Water Street Healthcare Partners LLC, as Executive Advisor from 2021.
Mr. Farhat also formerly worked at Surgalign Spine Technologies, Inc., as President, Chief Executive Officer & Director, American Medical Systems, Inc., as President & CEO from 2012 to 2015, Surgalign Holdings, Inc., as President, Chief Executive Officer & Director from 2017 to 2020, RTI Surgical, Inc. (Florida), as President & Chief Executive Officer from 2017 to 2020, Cardiac Science Corp., as Director from 2016 to 2019, CMR Surgical Ltd., as Director from 2018 to 2021, Lau Health Foundation, Inc., as Director from 2011 to 2016, Baxter International, Inc., as Global GM-Baxter Pharmaceuticals & Technologies from 2008 to 2011, General Electric Financial Services, Inc., as Principal from 1993 to 2001, Medtronic, Inc., as Vice President-Business Development from 2003 to 2006, Astora Women's Health, Inc., as President, NXThera, Inc., as Board Member from 2012 to 2015, GE Healthcare (Ventures), as Principal from 2001 to 2003, and Global Infusion Systems, as Principal.
Mr. Farhat received his Masters Business Admin degree in 1998 from Harvard University, undergraduate degree in 1991 from Northeastern University, and undergraduate degree from Sciences Po.

Camille R.
Bash is currently the Chief Financial Officer & Treasurer at Doctors Hospital, Inc. and a Fellow at Healthcare Financial Management Association.
Previously, she worked as the Chief Financial Officer at Washington Homes, Inc., Vice President-Business Operations at Children's National Hospital (District of Columbia), Administrator at Medlink Hospital & Nursing Center, and Chief Financial Officer at Catholic Charities.
Dr. Bash holds an MBA from the University of Missouri, an undergraduate degree from The University of Texas at Austin, and a graduate degree from Webster University.

Camille Olivere worked as a Principal at American Express Co., Oracle Corp., United Air Lines, Inc., and Signature Group.
She was also a Vice President-Sales at Travelport Americas, Inc. Olivere served as Senior Vice President-Sales at NCL Corp.
Ltd.
from 2009 to 2014 and at Norwegian Cruise Line Holdings Ltd.
from 2016 to 2020.
She was also Senior Vice President-Partner Brands at World Travel Holdings, Inc. from 2015 to 2016.
Olivere earned an undergraduate degree from the University of Michigan.

Camille Alexander is currently a Director at Schurz Communications, Inc. Previously, she worked as an Operations Manager at Meetup, Inc.

Camille Lee worked as Senior Vice President-Alzheimer Therapeutic Area at Biogen, Inc. from 2017 to 2018.
Prior to that, she was Vice President-Diabetes Marketing at Novo Nordisk, Inc. in 2013.
She also held the position of Vice President-International Marketing at Zürichsee Druckereien AG.
Ms. Lee earned an undergraduate degree from The California State University and an MBA from Scandinavian International Management Institute.

Camille Vela currently works as the Head of Customer Care at Keith Zars Pools Ltd.
Currently, Ms. Vela holds the position of Head of Customer Care at Keith Zars Pools Ltd.

Camille Diara has worked as a Director at MAAT Finances SA since 2005.

Camille V.
Otero is currently the Director-Real Property & Environmental at Gibbons PC, and a Member of both the New York State Bar Association and the New Jersey State Bar Association.
She received her undergraduate degree from Bloomfield College in 1995 and her graduate degree from Rutgers State University of New Jersey in 1998.

Ms. Camille S.
Andrews is Of Counsel at Context Capital Partners.
She brings more than 20 years of experience as a successful commercial litigator, law professor, and law school dean to her role with Context Capital Partners.
Additionally, Ms. Andrews has vast experience in complex commercial litigation, including antitrust, securities, corporate counseling, derivative shareholder litigation, and trademark and trade secret law.
Ms. Andrews was most recently both a litigation partner with the Philadelphia based firm of Dilworth Paxson, LLP, and an Associate Dean and Faculty member at Rutgers Law School.
At Rutgers, she taught Professional Responsibility (Ethics), Complex Litigation, Antitrust, Evidence,and Federal Practice.
In addition to her teaching duties, she also oversaw Enrollment and ICLE outreach courses to the bar.
In her capacity as Dean, she served as a member of the Judicial Clerkship Committee, Academic Petitions Committee, and faculty advisor to the Law Journal.
Ms. Andrews is admitted to practice before the U.S.
Supreme Court, New Jersey and Pennsylvania Supreme Courts, U.S.
District Courts for the Eastern District of Pennsylvania, Middle District of Pennsylvania & District of New Jersey, and the U.S.
Courts of Appeal for the Third & Second Circuits.
She is a member of several charitable boards, including Walnut Street Theatre, ACYO Foundation and New Jersey Child Cares.
She is married to Congressman Rob Andrews, and they have two daughters, Jackie and Josie.
The Andrews family lives in Haddon Heights, NJ.
Ms. Andrews received her undergraduate degree from the University of Pittsburgh and a graduate degree from Rutgers University.

Camille Simeon formerly worked at abrdn Australia Ltd., as Investment Director from 2020 to 2023.

Camille DeLuca-Flaherty worked as a Director of Development Project Management at Exelixis, Inc. from 1998 to 2012.
She also worked as a Vice President of Project Management at Catalyst Bioscience, Inc. and as a Principal at Affymax, Inc. and Sandoz Agro, Inc. Dr. DeLuca-Flaherty holds a doctorate degree from The University of Colorado.

Camille A.
Gerard is the founder of Risk Management Consulting LLC, which was founded in 2005.
Ms. Gerard's current job is as a Controller at Badlands Energy, Inc., starting in 2008.
Ms. Gerard has an MBA from Louisiana State University and an undergraduate degree from the University of Louisiana at Lafayette.

Camille Thommes worked as the Director General for the Association of the Luxembourg Fund Industry from 2007 to 2024.

Camille Cleveland is the General Counsel at Blue Nile, Inc. She previously worked as the Senior Vice President & General Counsel at A Place for Mom, Inc., the Executive Vice President & General Counsel at Big Boy Restaurant Group LLC, the Vice President & General Counsel at Entertainment Publications LLC, the Senior Legal Counsel at Ticketmaster Australasia Pty Ltd., and the Vice President & General Counsel at Papyrus-Recycled Greetings, Inc. Cleveland received her undergraduate degree from Albion College and her graduate degree from Wayne State University Law School.

Camille Landis worked as the Vice President of Business Development at Relypsa, Inc. from 2015 to 2017.
Prior to that, she was the Senior Vice President of Corporate Development at Unity Biotechnology, Inc. and the Chief Business Officer at Eidos Therapeutics, Inc. Ms. Landis received an undergraduate degree from the University of St. Thomas and an MBA from the Haas School of Business.

Camille Tan worked as a Sales & Trading Analyst at Deutsche Bank Securities, Inc. in 2014.
She also worked as an Analyst at Scotia Capital, Inc. (Broker).
From 2015 to 2018, she worked as a Research Analyst at Merrill Lynch, Pierce, Fenner & Smith, Inc. Ms. Tan received her undergraduate degree from The University of Waterloo in 2014.

Camille Cumberbath-Dhoray currently works at Petroleum Co. of Trinidad & Tobago Ltd., as Director.

Camille Claverie is a Non-Executive Director at ME Group International Plc since 2021.
Prior to this, Camille was a Partner at Montefiore Investment SAS starting in 2019.
Camille's former position was as a Director at Sagard SAS from 2015 to 2019.
Camille completed their graduate degree at École des Hautes Études Commerciales de Paris in 2007.

Camille P.
Wicher is currently the Vice President-Clinical Operations at Roswell Park Comprehensive Cancer Center since 1997.
She received a graduate degree from the State University of New York at Buffalo in 1987 and a doctorate degree from the same institution in 2013.

Camille R.
Robinson-Regis is currently a Member-Governors Board at the Inter-American Development Bank, Minister of Housing & Urban Development in the Government of Trinidad & Tobago, and a Member-Governors Board at the Inter-American Investment Corp.

Camille Fronville is currently working as an Investment Officer at BIO NV.

Camille Viot is currently the Chief Operating Officer at Asv Packaging since 2022.
Prior to this, Mr. Viot worked as a Director at Unicarton SA.

Camille Bonenfant currently works at ENGIE CC SCRL, as Director, Conces Franc Const Expl Tunnel Mont Blanc SA, as Director from 2019, and Storengy France SA, as Director.
Ms. Bonenfant also formerly worked at Compagnie Parisienne de Chauffage Urbain SA, as Deputy Chief Executive Officer in 2018, SFIG, as Chairman, ENGIE Énergie Services SA, as Director, and ENGIE SA, as Secretary.
Ms. Bonenfant received her graduate degree from Sciences Po.

Camille (Cami) focuses on healthcare with an emphasis on biotech, medical devices, and consumer health.
Temperamentally an early-stage investor and company helper, Cami currently serves on the board of Cavalry, Iris, Mahzi, Ocelot, Unity (UBX), and is a board observer at Interdict.
She previously served on the board of several exited Venrock portfolio companies, including Corvidia (sold to Novo), RegenXBio (RGNX), and Spirox (owned by Stryker).
Prior to Venrock, Cami was a Managing Director at Versant Ventures where she served on the board (or as a board observer) at many companies including Genomic Health (GHDX/sold to Exact), Jazz (JAZZ), Kythera (KYTH/sold to Allergan), and Novacardia (sold to Merck).
During her early career, Cami worked in corporate development at Genzyme, Millennium Predictive Medicine, and Tularik, and she was a management consultant at LEK.
Cami earned her Bachelor’s degree in Biology from Duke University and an MBA from Harvard Business School (HBS), where she graduated as a Baker Scholar.
She is a Henry Crown Fellow, serves on the Investment Advisory Committee of Mission BioCapital (MBC), and serves on the HBS Global Advisory Board.